Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Pancreatic Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma, Alveolar 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Mesothelioma, Malignant 1Lymphoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma 1

Interventions

Vincristine 4X-Rays 3Phantoms, Imaging 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Cyclophosphamide 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2ivosidenib 2cabozantinib 2Vemurafenib 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Nuclear Medicine Department, Hospital 2LY3023414 2Filgrastim 2Etoposide 2pegfilgrastim 1oncogene protein E7, Human papillomavirus type 16 1olaparib 1lexatumumab 1larotrectinib 1ganitumab 1fludarabine phosphate 1etoposide phosphate 1erdafitinib 1ensartinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Ewing × BAY 1895344 × Clear all
NCT05071209 2026-01-23

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
31 enrolled 14 charts
LymphoidSarcoma

Lymphoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡